Market Cap | ₹12Cr |
ROE | 51.39% |
P/E Ratio(TTM) | -4.06 |
EPS(TTM) | -7.67 |
P/B Ratio | 0.00 |
Dividend Yield | 0.00% |
Industry P/E | 40.19 |
Book Value | -7.21 |
Debt to Equity | -3.87 |
Face Value | 10 |
Parent Organisation | Parmax Pharma Limited |
BSE Symbol | 540359 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Divi's Laboratories | NA (0.00%) | 76.01 | ||
Neuland Laboratories | NA (0.00%) | 119.55 | ||
Jubilant Pharmova | NA (0.00%) | 38.33 | ||
Acutaas Chemicals | NA (0.00%) | 64.84 |